期刊文献+

高效液相色谱法测定多西他赛原料药的含量 被引量:1

Determination of Docetaxel Drug Substance by HPLC
下载PDF
导出
摘要 目的建立测定多西他赛原料药含量的方法。方法色谱柱为Kromasil C18(5μm,250mm×4.60mm),流动相:甲醇-水(75∶25),流速:1.0mL/min,检测波长:232nm。结果多西他赛原料药在高温、酸性和碱性条件下很不稳定,在氧化剂和光照条件下比较稳定,空白对照均无干扰;多西他赛浓度19.85~29.75μg/mL的范围内呈良好线性(r=0.9995),定量限为0.19μg/mL,检测限为0.052μg/mL,回收率在99.62%~100.06%之间,RSD为0.14%。结论该方法操作简便、灵敏、准确度高,可用于多西他赛原料药的质量控制。 Objective To establish a method for determination of docetaxel drug substances.Methods The analysis was performed on Kromasil C18 column(250 mm×4.6mm,5μm) with detective wave length at232 nm.The mobile phase consisted of a mixture of methanol and water(75∶ 25) with the flow rate of 1.0ML/min.Results Docetaxel drug substance is not stable in the high temperature,acidic and alkaline conditions,but is relatively stable in the oxidant and light conditions.There is no interference in the blank control.Docetaxel concentration of 19.85μg/mL to 29.75μg/mL showed good linearity(r=0.9995).The limit of quantification was 0.19μg/mL and the detection limit is 0.052μg/mL.The recovery rate was 99.62%~100.06% and RSD0.14%.Conclusion This method is simple,sensitive,accurate and available for quality control of docetaxel drug substance.
出处 《湖北科技学院学报(医学版)》 2017年第1期3-5,共3页 Journal of Hubei University of Science and Technology(Medical Sciences)
关键词 多西他赛原料药 含量测定 高效液相色谱 Docetaxel drug substane Content determination HPLC
  • 相关文献

参考文献4

二级参考文献34

  • 1Teagarden DL,Baker DS.Practical aspects of lyophilization using non-aqueous co-solvent systems[J].Eur J Pharm Sci,2002,15 (2):115-133.
  • 2Wittaya-Areekul S,Needham GF,Milton N,et al.Freezedrying of tert-butanol/water cosolvent systems:a case report on formation of a friable freeze-dried powder of tobramycin sulfate[J].J Pharm Sci,2002,91 (4):1147-1155.
  • 3Loos W J, V erweij J, Nooter K, et al. Sensitive determination of docetaxel in human plasma by liquid -liquid extraction and reversed - phase high - performance liquid chromatography [ J]. J Chrom - atogr B Biomed Sci, 1997, 693 (2) :437 -439.
  • 4Ciccolini J, Catalin J, Blachon MF, et al. Rapid high - performance liquid chroma - tographic determination of docetaxel in plasma using liquid -liquid extraction [ J]. J Chromato B ,2001,299 (8) :759 -761.
  • 5Dandekar P, Jain R, Stauner T, et al. A hydrophobic starch polymer for nanoparticle-mediated delivery of docetaxel [J]. Macromol Biosci, 2012, 12 (2) : 184-194.
  • 6Bardelmeijer HA, Ouwehand M, Buckle T, et al. Low systemic exposure of oral docetaxel in mice resulting from extensive first-pass metabolism is boosted by ritonavir [J]. Cancer Res, 2002, 62 (21): 6158-6164.
  • 7Park JH, Kim Y J, Kwon KE, et al. Effects of formulation on pharmacokinetics of docetaxel in rats [J]. JPharm Investig, 2012, 42 (1) : 51-55.
  • 8Li H, Dong WF, Zhou JY, et al. Triggering effect of N-acetylglucosamine on retarded drug release from a leetin- anchored chitosan nanoparticles-in-microparticles system [J]. Int J Pharm, 2013, 449 (1-2) : 37-43.
  • 9Li FQ, Ji RR, Chen X, et al. Cetirizine dihydrochloride loaded microparticles design using ionotropic cross-linked chitosan nanoparticles by spray-drying method [J]. Arch Pharm Res, 2010, 33 (12) : 1967-1973.
  • 10Kim CK, Yoon YS, Kong JY. Preparation and evaluation of flurbiprofen dry elixir as a novel dosage form using a spray- drying technique [J]. Int J Pharm, 1995, 120 (1) : 21-31.

共引文献19

同被引文献14

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部